demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 outpatients
interferon
inhaled interferon
SNG001 inhaled interferon beta ACTIV-2 SNG001
peginterferon TOGETHER interferon lambda Feld

7 studies excluded by filtering options 3

4861 Cai -FAVIPIRAVIR, 2020 1310not a RCTrisk of bias not avaialble
5183 Qiong Zhou, 2020 0190selection pending
5450 Pereda, 0 0100selection pending
5534 Wang (early IFN), 2020 0134selection pending
5565 Pereda, 2020 0130selection pending
5572 Hao, 2020 0200selection pending
6140 Wang, 2020 0130selection pending